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Critically ill patients who require MV are at risk for a number of complications, 
including the development of ventilator-associated events (VAE) and agitation that may 
require the use of sedation. Patients experience anxiety and discomfort during 
mechanical ventilation from a variety of sources including unfamiliar breathing 
assistance and an inability to communicate anxiety and pain verbally, but a primary 
cause of discomfort identified by these patients is the simply the presence of the 
endotracheal tube (ETT). Discomfort often leads to agitation and may be exacerbated 
by ETT movement. Management of agitation typically involves the use of sedative 
therapy and has been shown to increase the length of stay in the hospital. Additionally, 
when ETT cuff pressure is not adequately maintained, risk of microaspiration increases 
and these microaspirations increase the risk of ventilator-associated events.  ETT 
movement may adversely affect the cuff seal against the tracheal mucosa, increasing 
leakage around the cuff and microaspiration.  To date, no studies have described the 
 
 
 
effect of ETT movement on patient comfort and agitation. Noting the frequency of ETT 
movement during the provision of nursing care and plausible inadvertent consequences 
on discomfort and agitation, a research model was created and specific instruments 
selected in order to study this topic.  This dissertation will provide a review of the 
literature regarding the role of the ETT in microaspiration, as well as detail a study that 
explores the frequency and amount of ETT movement and its potential effect on 
agitation. 
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  Introduction 
 
While ICUs account for only a small percentage of hospital beds, ICU costs make up 
a larger proportion of the inpatient costs and much of this cost can be attributed to 
interventions such as mechanical ventilation (MV).  Mechanically ventilated patients 
have longer ICU length of stay (LOS), incur significantly higher costs per day than non-
mechanically ventilated patients and have a crude mortality rate that is significantly 
higher.1 Critically ill patients who require MV are at risk for a number of complications, 
including the development of ventilator-associated events (VAE) and agitation that may 
require the use of sedation.2 MV is often prolonged in patients who develop such 
complications related to MV. Given the high daily costs, and considering the number of 
patients who require critical care for sustained periods of time, attention to interventions 
that result in even nominal decreases in duration of MV or ICU LOS have the potential 
to significantly reduce overall hospital costs. 
Patients experience anxiety and discomfort during mechanical ventilation from a 
variety of sources including unfamiliar breathing assistance3 and an inability to 
communicate anxiety and pain verbally.4 . A primary cause of discomfort identified by 
these patients, however, is the simply the presence of the endotracheal tube (ETT).5, 6 
This discomfort often leads to agitation5 and may be exacerbated by ETT movement. 
Agitation is most often described as excessive restlessness, usually non-purposeful 
physical activity, associated with internal tension, anxiety, or emotional distress.7, 8  
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Agitation has been shown to increase the length of stay in the hospital.9, 10 Management 
of agitation involves the use of sedative therapy, as most ICU patients receive 
intravenous (IV) sedation to help alleviate the pain, anxiety and agitation accompanying 
MV.11, 12 Topical local anesthetics applied to the ETT have been shown to mitigate ETT 
discomfort13 resulting in reduced need for IV sedative agents in MV patients.14 Reducing 
agitation and the use of sedation is associated with shorter duration of MV and ICU 
length of stay. Therefore describing ETT movement and its effect on discomfort and the 
resulting agitation is a first step towards developing interventions that may improve 
outcomes in critically ill patients. 
The design of the ETT used during MV includes a cuff that surrounds the distal 
aspect of the tube and is inflated against the tracheal wall.  The inflated cuff  prevents 
leakage of air and subsequent loss of pressure from the lungs during MV, and reduces 
the aspiration of oral secretions into the lower airway.15 However, these oral secretions 
may move beyond the ETT cuff even when the cuff is properly inflated.16, 17 Therefore, 
when ETT cuff pressure is not adequately maintained, risk of microaspiration increases 
and these microaspirations increase VAE risk.18 ETT movement may adversely affect 
the cuff seal against the tracheal mucosa, increasing leakage around the cuff and 
microaspiration.  Chapter 2 will detail the existing literature regarding the ETT and the 
role of the ETT cuff in microaspiration and demonstrate the need for further research in 
this area. 
To date, no studies have described the effect of ETT movement on patient comfort 
and agitation. Noting the frequency of ETT movement during the provision of nursing 
care and plausible inadvertent consequences on discomfort and agitation, a research 
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model was created and specific instruments selected in order to study this topic (Figure 
1).  The primary aim of this study was to describe ETT movement and its effect on 
patient discomfort and agitation.  A secondary aim was to describe the effect of nursing 
care and patient activities on ETT movement.  
 
Figure 1 
RESEARCH MODEL: 
 
Not only do patients move themselves, but critically ill patients are moved frequently 
during their care, to reduce complications of immobility, for medical and nursing 
procedures and for comfort. As a result, the ETT with the attached ventilator tubing is 
frequently moved from side to side and up and down during these care activities. This 
ETT movement may cause discomfort that can lead to agitation. Agitation in the 
critically ill has a significant negative impact on patient outcomes due to its physiologic 
complications, increased duration of MV and ICU length of stay, as well as increased 
hospital costs.19 Therefore description of ETT movement and its effect on discomfort 
Endotracheal Tube 
Movement 
 Dual axis 
accelerometers 
Discomfort 
● BPS  
   
  
Nursing care 
affecting     
movement 
(examples) 
-turning patient 
-raise/lower HOB 
-shift vent tubing 
-ETT suctioning 
Agitation 
● Actigraphy 
● RASS
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and the resulting agitation is an important first step in reducing the negative 
consequences of agitation in the critically ill.  
In summary, MV is a common intervention in the critically ill and the costs of 
associated complications, both human and economic, are high. Therefore it is important 
to identify all factors that may affect the development of these complications.  Although 
no studies to date have described the effect of routine ETT movement on patient 
comfort and agitation, these relationships may have a significant impact on patient 
outcomes.  The study discussed in Chapter 3 will be the first to describe ETT movement 
and its effect on patient discomfort and agitation and may provide data to develop 
interventions to reduce these effects in the MV population.  Twenty-one MV patients 
were continuously monitored for ETT movement, as well as indicators of discomfort and 
agitation, for up to four hours. It was found that the ETT moves nearly continuously and 
often large distances over time. While this analysis did not show strong correlations 
between ETT movement and discomfort/agitation (likely due to small sample size), it did 
illustrate the need for further research regarding the impact of this routinely large 
amount of ETT movement. 
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a b s t r a c t
The cuff of the endotracheal tube (ETT) is designed to provide a seal within the
airway, allowing airflow through the ETT but preventing passage of air or fluids
around the ETT. Deliberate or inadvertent movement of the ETT may affect cuff
pressure or shift folds in the cuff, mobilizing pooled secretions. When this seal is
compromised, microaspirations contaminated with gastric contents or bacteri-
ally colonized oral secretions can occur that leave the patient susceptible to
a host of problems, such as hypoxia, pneumonitis, and respiratory infections.
These complications are costly in terms of morbidity and mortality, as well as
hospital expense. We will discuss the role of the ETT cuff in microaspiration and
identify potential directions for future research to improve outcomes in
mechanically ventilated patients.
Cite this article: Hamilton, V. A., & Grap, M. J. (2012, MARCH/APRIL). The role of the endotracheal tube cuff
in microaspiration. Heart & Lung, 41(2), 167-172. doi:10.1016/j.hrtlng.2011.09.001.
Leakage of fluid around the cuff of the endotracheal
tube (ETT) into the airway is a potentially serious form
of microaspiration. The cuff is designed to provide
a seal with the airway, allowing airflow through the
ETT but preventing passage of air or fluids around the
ETT. When this seal is compromised, microaspirations
contaminated with gastric contents or bacterially
colonized oral secretions can occur that leave the
patient susceptible to a host of problems, such as
hypoxia, pneumonitis, and respiratory infections.
Hypoxic events have been shown to accompany
aspiration in mechanically ventilated patients.1 Pneu-
monitis and ventilator-associated tracheobronchitis
(VAT)canalso result fromaspirationofgastric contents.
VAT has been suggested to be an early stage of the
ventilator-associated pneumonia (VAP) pathway.2 VAP
is associated with increased duration of mechanical
ventilation (MV), intensive care unit (ICU) length of stay
(LOS), mortality, and overall hospital costs.3,4
There are many factors that contribute to the
development of VAP as a result of microaspiration,
including the presence (or absence) of accumulated
subglottic secretions above the cuff (Figure 1) and the
inability of the ETT cuff to maintain a seal within the
airway.5 This article will discuss the role of the ETT cuff
in microaspiration and identify potential directions for
future research to improve outcomes in mechanically
ventilated patients.
* Corresponding author: V. Anne Hamilton, MS, RN, FNP, 9600 Chanelka Ln, Richmond, VA 23832.
E-mail address: vahamilt@vcu.edu (V. A. Hamilton).
0147-9563/$ - see front matter  2012 Elsevier Inc. All rights reserved.
doi:10.1016/j.hrtlng.2011.09.001
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Materials and Methods
Microaspiration: Relationship to Ventilator-
Associated Tracheobronchitis and Pneumonia
VAT is not uncommon among intubated acutely ill
patients,6 with a 2010 review finding an incidence as
high as 11.5%.7 VAT represents an intermediate process
between lower respiratory tract colonization and VAP.8
In the most recently published guidelines of the
American Thoracic Society and the Infectious Disease
Society of America on health care-associated pneu-
monia,9 VAT is regarded as a type of lower respiratory
tract infection and as an alternative diagnosis for
patients with possible VAP. VAT is defined using the
following criteria: fever (>38C) with no other recogniz-
able cause, purulent sputum production, positive
culture of respiratory specimen at significant threshold,
and no radiographic signs of new pneumonia.10 This
infection is characterized by lower respiratory tract
inflammation and increased sputum production that
result in weaning difficulties and longer duration of
MV.10VATisoftentheprecursor toVAP. Ina randomized
controlled trial conducted by Nseir et al,11 58 patients
with clinically diagnosed VAT were randomly assigned
to routine treatment or antibiotic therapy. A significant
reduction in ICUmortality (18%vs47%;P¼ .047) andVAP
(13% vs 47%; P ¼ .011) was identified in the antibiotic
treatment group, indicating that intervention early in
this pathway may prevent the development of VAP.
VAP is defined as a pulmonary infection that occurs
48 hours or more after endotracheal intubation
(in patients with no evidence of pneumonia at the time
of intubation).9Microaspirationof subglottic contents is
a contributing factor to the development of VAP.5
During MV, oral secretions move from the oral cavity
and pool above the ETT cuff. Colonization of these
secretions with pathogenic organisms is nearly
unavoidable, and the relationshipwithmicroaspiration
of these secretions and VAP is well established.12-15 Of
patients requiringMV, up to 8% to 28%developVAP.16,17
Studies have shown that patients with VAP have
significantly longer ICU LOS,18 an additional $40,000 in
hospital costs,4,19 and mortality rates up to 76% versus
32% compared with MV patients without VAP.4,20,21
With increased overall costs and mortality rates, it is
critical to identify all factors potentially contributing to
VAP to reduce risk.HealthyPeople2020 (archivedhealth
status objective 14-20e) includes a goal to reduce the
incidence of VAP in ICU patients by at least 10%.22 The
AmericanThoracic Societyupdate of researchpriorities
for nursing addresses an “emphasis on nursing inter-
ventions that decrease the incidence of ventilator-
associated pneumonia.”23 In addition, the 5 Million
Lives Campaign to reduce ICU mortality, initiated by the
Institute for Healthcare Improvement, has at its core,
interventions to reduce VAP, that is, the VAP bundle.24
This continued focus on VAP prevention illustrates the
importance of interventions aimed at reducing risks.
Factors Affecting Microaspiration
Subglottic Secretions
One of the primary preventive measures for VAP
includes reducing the risk of aspirating oral secretions
by preventing accumulation of bacteria-laden secre-
tions above the ETT cuff or minimizing leakage
between the cuff and the tracheal wall. Four random-
ized prospective studies have evaluated the effect of
removal of the secretions via intermittent or contin-
uous aspiration of subglottic secretions (CASS) on the
development of VAP.12,13,15,25 In all 4 studies, the inci-
dence of VAPwas reduced. In 101 randomized patients,
Yang et al26 demonstrated that those with CASS
had significantly lower morbidity of VAP (25% vs 46.5%,
P ¼ .032) and delay of onset of VAP (7.3  4.2 days vs 5.1
 3.0 days, P ¼ .100). In another randomized study that
spanned 2 years and included 714 patients undergoing
cardiac surgery, subglottic secretion removal demon-
strated a significant reduction in the incidence of VAP,
ICU LOS, antibiotic use, and overall mortality.27
Evidence showing that removal of subglottic secre-
tions reduces the incidence of VAP suggests that
reducing microaspiration is an appropriate and effec-
tive method to also reduce VAP.
Endotracheal Tube Cuff Pressure
To prevent potential microaspirations around the ETT
cuff, maintenance of adequate cuff pressure is essen-
tial.28-30 Although sealing the airway around the ETT
cuff by high inflation pressure would be effective, high
pressures threaten perfusion and integrity of the
Figure 1 e Pooled secretions above the cuff leaking
into the airway. Image used by permission from
Nellcor Puritan Bennett LLC, Boulder, Colorado,
doing business as Covidien.
h e a r t & l ung 4 1 ( 2 0 1 2 ) 1 6 7e1 7 2168
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tracheal mucosa.28,31 Excessive pressure may compro-
mise the microcirculation of the tracheal mucosa and
cause ischemic lesions.29,32 ETT cuff pressure is rec-
ommended to be maintained within 20 to 30 cm H2O to
provide an adequate seal without compromising
mucosal perfusion.5,33 However, insufficient cuff pres-
sure impedes ventilation with positive pressure and
may allow the passage of subglottic secretions.34 Rello
et al35 analyzed the effect of cuff pressure on the
development of VAP in 83 patients undergoing CASS
and showed that CASS failure (when subglottic secre-
tions were not continuously removed) and persistent
intracuff pressures less than 20 cmH2Owere associated
with a significantly increased risk of pneumonia. They
demonstrated that leakage around the cuff is the risk
factor of greatest importance for VAP within the first 8
days of MV.
Valencia and colleagues36 assessed the efficacy of an
automatic ETT cuff pressure control device in opti-
mizing cuff pressures and preventing VAP develop-
ment. MV patients (n ¼ 142) with no prior diagnosis of
pneumonia were randomly assigned to the treatment
group (continuous cuff pressure control) or control
group (routine ETT cuff care), with the end point being
the incidence of VAP. Investigators were able to
maintain ETT cuff pressures within target range (20e30
cm H2O) in approximately 80% of the treatment group.
Only .7% of the treatment group patients had cuff
pressures less than 20 cm H2O compared with
approximately 45.3% in the control group (P ¼.001).
Although investigators did not demonstrate a statisti-
cally significant difference in the pneumonia rate
between the groups (29% control vs 22% automatic
cuff), a few possible explanations exist for this finding.
Automatic devices might generally maintain cuff
pressure well, but the response time during a coughing
episode might be too slow and allow a compromise in
airway seal for just milliseconds.36 This can lead to the
unnoticed microaspiration that occurs with constant
cuff pressures. Although 20 cm H2O is the commonly
used pressure to provide sufficient sealing with
minimal damage to mucosa, as changes occur in the
airway (with movement or coughing), a constant
pressure may not be adequate to ensure a constant
seal. Chadha et al37 showed in a randomized controlled
study in a porcine model (n ¼ 10) that dynamic cuff
pressure modulation (varying with inspiration and
expiration) significantly reduced laryngotracheal
mucosal injury while providing a more consistent seal
with the trachea. These findings suggest that research
into the effects of movement on ETT cuff pressure in
MV humans is warranted.
Sole and colleagues38 demonstrated that ETT cuff
pressures change over time by measuring cuff pres-
sures of 23 intubated patients at 4-hour intervals over
a 12-hour shift. All patients showed statistically
significant decreases in cuff pressure at each
measurement interval (4, 8, and 12 hours), with many
experiencing clinically significant (>10%) decreases in
pressure.38 In a multisite survey, Sole and colleagues39
found that ETT cuff pressures are typically checked,
according to institutional policies, only at change of
shift (every 8 to 12 hours) or as indicated by suspicion
of cuff leak. Frequently estimated by palpation of the
pilot balloon, ETT cuff pressure is often significantly
lower than estimated by caregivers.40 These periods of
insufficient pressure leave the patient susceptible to
microaspiration, because secretions pooled on top of
the ETT cuff may move past it. Movement of the ETT
may affect cuff pressure enough to provide this avenue
into the lungs.
In a 2011 crossover design study including 32 orally
intubated patients, Sole and colleagues41 used alarms
as triggers for intervention to correct out of range cuff
pressures. They found that 51.7% of cuff pressures
were out of range during the control period compared
with 11.1% during the intervention (P < .001). Sole and
colleagues38,42 have shown that continuous cuff pres-
sure monitoring is possible and may be necessary to
consistently monitor and maintain optimal cuff
pressure.37,41
Folds in Endotracheal Tube Cuff
The ETT cuff is designed to provide enough pressure to
seal the airway without causing perfusion problems in
the tracheal mucosa. The cuff itself is made of a pliable
medical grade polyvinylchloride (PVC) and forms to the
airway as it is inflated.43 Because patients have physi-
ologic and anatomic differences, it can require different
amounts of air injected to reach target ETT cuff pres-
sure.Asa result, the cuff is inflated ina slightly different
configuration with a potentially different volume of air
Figure 2 e Microchannels form as the result of
variations in patient airways. A polyurethane cuff
designed to eliminate leakage through these folds is
shown. Image used by permission from Nellcor
Puritan Bennett LLC, Boulder, Colorado, doing
business as Covidien.
h e a r t & l ung 4 1 ( 2 0 1 2 ) 1 6 7e1 7 2 169
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with each ventilated patient. This high-volume, low-
pressure (HVLP) “one size fits all” PVC cuff leaves room
for an incompletely inflated cuff that, while inflated to
recommended pressures, can create channels or
passageways for secretions to circumvent the ETT cuff
(Figure 2).43 The leakage of secretions despite using
clinically appropriate ETT cuff pressure has been
hypothesized to be related to the formation of folds in
the cuff that allow longitudinal leakage.43-46 Movement
of the ETT may exacerbate the effect of these folds,
shifting them and mobilizing pooled oral secretions.
The elimination of leakage around the cuff has
been achieved with the use of lubricating gels that fill
the cuff channels.47,48 Blunt and colleagues47 placed
dye in the subglottic space and observed for leakage
into the tracheobronchial tree in 2 different studies. In
their in vitro model, leakage was 0% for cuffs treated
with water-soluble gel and 100% for non-treated cuffs.
In a double-blind randomized study in anesthetized
patients (n ¼ 36), the lubricated group had 11%
leakage and the non-lubricated group had 83% leakage
(P < .0001).
Another study targeting leakage around the ETT
was conducted by Young and colleagues.49 They used
the dye-leakage method to test a low-volume, low-
pressure (LVLP) ETT cuff in a rigid tracheal model, an
in vitro pig trachea model, and a randomized con-
trolled trial of 38 anesthetized patients. Leakage was
0% for the rigid tracheal model and the pig trachea
model in the LVLP cuffs, whereas it was 100% and 79%,
respectively, in the standard HVLP cuffs. In the patient
trials, leakage was 5% in the LVLP group and 67% in the
HVLP group.49 Because the LVLP cuff requires a lower
volume, it theoretically does not form the longitudinal
folds that an HVLP cuff does when inflated to seal,
whereas it provides reliable pressure against the
tracheal wall. However, it has not, been demonstrated
whether these improvements in ETT cuff seal will
lower the incidence of VAP.
The use of different types of ETT cuffs has also been
investigated to reduce the incidence of cuff folds. A
variety of different materials and designs have been
investigated, including latex, silicone, and poly-
urethane. Several studies have shown that poly-
urethane cuffs are superior to conventional PVC cuffs
in the prevention of microaspiration.50-53
Endotracheal Tube Movement
Securement of the ETT is generally driven by institu-
tional policy. The ETT is frequently secured with
surgical tape that holds the tube at a specific depth,
but does little to limit lateral movement of the tube
around that site. Multiple studies have attempted to
determine which method of securement is ideal,54-57
but there is little evidence that any particular device
or technique is superior to any other.58 Overall, the
data suggest that it is less expensive, more conve-
nient, and just as effective to use standard white
surgical tape to secure the ETT as any other alterna-
tive method.54,56 Unfortunately, none of these studies
has examined the amount or effect of lateral and
longitudinal movement of the ETT based on secure-
ment method.
When nursing care is administered, the ETT is often
moved deliberately or inadvertently. The ETT is delib-
erately moved periodically to prevent breakdown of
oral mucosa and often repositioned to improve access
when providing patient care and to facilitate effective
oral care. The ETT also moves when the patient is
turned (manually by nursing staff or automatically by
specialty mattress/bed), when the patient moves
independently, or when the ventilator tubing is
disturbed. Although the tube is secured well enough to
maintain the depth of intubation, anecdotal evidence
suggests that nurses often provide patient carewithout
extra attention paid to lateral and rotational move-
ment of the ETT tube. Kim et al,59 using a fiberoptic
bronchoscope, observed movement of the ETT tip in 24
anesthetized adults during flexion, extension, and
rotation of the head. Although Kim et al documented
measurements only related to distance from the
carina, they demonstrated clear movement of the ETT
during these positional changes.59 It is possible that
this movement affects cuff seal, although this has not
been specifically investigated. Because movement of
the ETT, both deliberate and inadvertent, is frequent
and often not considered during routine care, closer
investigation of the potential impact of ETT movement
is warranted.
Conclusions
It is clear that microaspiration continues to be
a significant contributor to the development of VAP
despite advances in the design and care of the ETT cuff.
Although continuous removal of bacteria-laden sub-
glottic secretions has been shown to reduce the inci-
dence of VAP, complete removal of all potential
pathogens is difficult, and removal of subglottic
secretion is not included in VAP prevention bundles. It
has been demonstrated that maintenance of ETT cuff
pressures in the recommended target range is, at
times, not adequate to prevent microaspirations.
Changes in cuff pressure occur and can affect the ETT
cuff’s ability to maintain a seal against the tracheal
wall, increasing the risk of aspirating oral secretions.
Determining the role of the ETT cuff inmicroaspiration
is the first step toward understanding how movement
of the ETT itself may affect the risk of microaspiration
and the subsequent development of VAP.
Directions for Future Research
Identifying and understanding actions that increase
a patient’s risk of life-threatening complications is only
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the first step in reducing risk. Research to describe the
types of ETT movement and the nursing care that
affects movement is currently under way. Further
research into oral care interventions that reduce the
level of colonization of oral secretions and studies to
determine the best method of ETT securement to
reduce lateralmovement are areas of potential interest.
Using ETTs with cuffs made of various materials or
studies that test methods to reduce the impact of folds
in the cuff are possible avenues to reach better patient
outcomes. Future research may be directed toward
nursing interventions that minimize the impact of ETT
movement. Asweunderstandmore about the impact of
nursing interventions on the movement of the ETT, we
can direct future research specifically to address
improvement in patient outcomes.
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ABSTRACT 
Background:  Critically ill patients who require mechanical ventilation (MV) are at risk for a 
number of complications, including the development of ventilator-associated events and 
agitation that may require the use of sedation. The longer the duration of MV, the higher these 
risks may be. Patients experience anxiety and discomfort during mechanical ventilation from a 
variety of sources and discomfort often leads to agitation, which might be exacerbated by ETT 
movement. Most ICU patients receive sedation to help alleviate the pain, anxiety and agitation 
accompanying MV. Reducing agitation and the use of sedation can reduce duration of MV and 
ICU length of stay.  
Objectives:  The primary purpose of this study was to describe ETT movement and explore its 
effect on discomfort and the resulting agitation, as a first step toward developing interventions 
that may improve outcomes in critically ill patients. A secondary aim was to describe nursing 
and patient activities associated with ETT movement. 
Methods:  Thirty three intubated patients from a medical respiratory ICU were enrolled and data 
was collected for up to four hours. During the study period, ETT movement was measured with 
a magnetic tracking system, agitation was measured with both continuous actigraphic 
monitoring on the arm and leg and periodic assessment with the Richmond Agitation Sedation 
Scale, and comfort was evaluated with the Behavioral Pain Scale. Continuous observation 
during the study period allowed recording of visual confirmation of activities that affect ETT 
movement. 
Results:  There were 58.5 hours of direct patient observation with a mean of 2.8 hours of 
observation per patient.  Very weak correlations were found between ETT movement and both 
actigraphy (arm: r = 0.11; p<.001 and leg: r = 0.07; p<.001) and measures of discomfort (r = -
.06; p = 0.78) and agitation (r = .30; p = 0.19). On average 26.4 minutes were spent in nursing 
or patient activities that affected ETT movement.  However, there was no association between 
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total ETT movement and total time spent in any activity (r = 0.06; p = 0.81) by subject, nor were 
there any significant associations among ETT movement and any category of nursing or patient 
activity 
Conclusions:  This paper reports the first description of ETT movement other than ETT 
migration. Critically ill patient experiences of pain and discomfort, as well as risk of 
microaspiration, are a critical focus of nursing care, but standards of care for managing ETTs do 
not necessarily focus on ETT movement, except to ensure ETT stability related to depth. 
Although we did not find an association in this study, additional movement, as we have shown, 
occurs continuously (side to side, up and down) and may add to further pain and agitation as 
well as the potential to reduce cuff pressure resulting in microaspiration.  To further reduce 
overall risks and complications of MV, exploration of the effect of ETT movement on both 
agitation causing discomfort and cuff pressure changes that could increase risk of ventilator-
associated events due to microaspiration is in order. A reduction in these complications may 
have a positive impact on patient outcomes including decreasing duration of MV, ICU and 
hospital length of stay.  
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Critically ill patients who require mechanical ventilation (MV) are at risk for a number of 
complications, including the development of ventilator-associated events (VAE), such as 
ventilator-associated pneumonia, and agitation that may require the use of sedation.1 The 
longer the duration of MV, the higher these risks may be, therefore factors that may increase the 
amount of time a patient is intubated are important to understand. The endotracheal tube (ETT) 
design includes a cuff that, when inflated, contacts the tracheal wall and creates a seal that 
allows air to flow through the tube and prevents bacteria-laden oral secretions from entering the 
lower airways. It has been well-documented that changes in head and neck position affect ETT 
cuff pressures,2-5 which may increase the risk of microaspirations and/or tracheal wall damage 
due to wide fluctuations in cuff pressure.  Much literature exists about ETT movement, in terms 
of displacement and how that may affect cuff pressure. One recent study showed that after 
position change, 91.7% of patients had ETT tube displacement. Of these patients, 48% of ETT 
moved ≥ 10 mm, 86.3% had changes in cuff pressure and there was a slight but significant 
correlation between ETT movement and change in cuff pressure. MINOLittle is known, however, 
about lateral and/or rotational ETT movement, i.e., how frequently it occurs, the degree of 
movement and the types of activities associated with this movement. ETT movement may also 
increase microaspiration as the cuff seal in the trachea or cuff pressure may be adversely 
affected during ETT movement.6 In addition, studies have shown that the presence of an 
endotracheal tube is a major source of discomfort,7-10 but the effect of ETT movement on that 
discomfort and agitation is yet unknown. 
Patients experience anxiety and discomfort during mechanical ventilation from a variety 
of sources11such as unfamiliar breathing assistance and an inability to communicate anxiety and 
pain verbally,12 but a primary cause of discomfort in these patients is the presence of the ETT.10 
This discomfort often leads to agitation which might be exacerbated by ETT movement; 
conversely patient movement accompanying agitated behavior may affect ETT movement, as 
well. Most ICU patients receive intravenous (IV) sedation to help alleviate the pain, anxiety and 
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agitation accompanying MV.13, 14 Topical, local anesthetics on the ETT have been shown to 
mitigate discomfort15 and reduce the need for sedation in MV patients.16 Reducing agitation and 
the use of sedation also reduces duration of MV and ICU length of stay. However, there are no 
data that describe the type and amount of ETT movement, activities or the level of agitation 
associated with ETT movement. Therefore the primary purpose of this study was to describe 
ETT movement and explore its effect on discomfort and the resulting agitation, as a first step 
toward developing interventions that may improve outcomes in critically ill patients. A secondary 
aim was to describe nursing and patient activities associated with ETT movement. 
 METHODS 
Subjects and Setting 
This study was conducted at the Virginia Commonwealth University Health System 
(VCUHS) in Richmond, Virginia, a 933-bed tertiary care university medical center with a 232-
bed critical care hospital, located in an urban area.  Approximately 48% of admissions are 
African American, 42% white, 5% Hispanic, and 5% other/unknown. The hospital offers a wide 
range of patient care services, including all critical care specialties. This study was conducted in 
the Medical Respiratory Intensive Care Unit (MRICU). This study was approved by the 
University’s Institutional Review Board and consent for participation was obtained from each 
patient’s legally authorized representative (LAR) prior to enrollment in the study. 
A projected sample of up to 35 subjects was to be enrolled from all patients admitted to 
the MRICU. Male and female adults from all racial/ethnic backgrounds were recruited. Exclusion 
criteria were: patients with chronic, persistent neuro-muscular disorders (such as cerebral palsy 
or Parkinson’s disease) and patients with head trauma or stroke, as these may affect patient 
movement and study measurements.  
Key Variables and Their Measurement 
ETT Movement.  A TrakStar magnetic tracking system (Ascension Technologies, 
Shelburne, VT) was used to measure movement of the ETT relative to the patient.  Pilot testing 
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of this innovative technique was performed to establish the most effective and accurate 
methods for data collection. To identify ETT movement independent of head movement, one 
small sensor (2mm) was placed in the center of the patient’s forehead, as a reference point for 
movement of the ETT tube, and one was placed directly onto the ETT as close to the lip as 
possible. The transmitter that received signals from these sensors was affixed to the head of 
bed (HOB) so that any movement of the bed itself would not alter the perceived position of the 
reference point. The tracking system recorded data at 60Hz (60 times per second) and collected 
information regarding the positions of the 2 sensors on the x, y and z axis, including orientation 
angles for azimuth, elevation and roll. These values were used to determine the magnitude of 
ETT movement.  
Discomfort. Discomfort was measured using the Behavioral Pain Scale (BPS),17 a 
commonly used tool in intubated patients who are unable to communicate, which assigns a 
value of 1 through 4 to three categories: facial expression, upper limb movement, and 
compliance with ventilation with an overall score ranging from 3 to 12. Each pain indicator is 
scored from 1 (no response) to 4 (full response), with the assumption that a relationship exists 
between each score and pain intensity. The BPS is based on a sum score of these three items. 
Scores greater than 6 are often considered to indicate the need for pain interventions. The BPS 
demonstrated good validity when used during noxious and non-noxious stimulation and had 
inter-rater reliability ranging from .50 -.71.17, 18 Chanques et al.,19 evaluated pain using the BPS 
(in nonverbal patients) and numeric self-report (NRS) and found no significant difference in the 
rate of severe pain events between the two groups. 
Agitation. Two measures of agitation, actigraphy and the Richmond Agitation Sedation 
Scale (RASS) were used. The actigraph (Basic Motionlogger, Ambulatory Monitoring Inc, 
Ardsley, NY) was placed on the wrist and the ankle and used to measure agitation. Actigraphs 
were placed on both the wrist and the ankle to capture any movement of either upper or lower 
limbs as a result of agitation. The Motionlogger actigraph is a small, lightweight, limb-worn 
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activity monitoring device that measures long-term gross motor activity and integrates degree 
and intensity of motion. It contains a single omnidirectional accelerometer that is capable of 
sensing any motion with minimal acceleration of 0.01 g and integrates occurrence, degree and 
intensity of motion to produce activity counts. Internal memory and programming allows the 
actigraph to store data for long periods of time. Through a wireless data transfer system, data 
from the actigraph can be read and exported to a data base program.  
Wrist actigraphy has been used to monitor activity levels in subjects for sleep, circadian 
rhythms, pain, or drug response and has been found to be a reliable method of assessing 
activity/agitation in the critical care setting.20 Actigraphy is easy-to-use and has a long history of 
use in other populations. It has been used to track circadian rest-activity cycles21 and to identify 
states of wakefulness and sleep.22 Automatic scoring of wrist and ankle activity will provide 
valuable continuous information about patient activity and agitation. In a prospective evaluation 
to test procedures for the measurement of agitation of 20 adult medical ICU patients, it was 
found that actigraphy was significantly correlated with the RASS (p < 0.001), and the Comfort 
Scale (p < 0.05).20  When compared to presently used sedation scales and direct observation of 
behavior, actigraphy has been shown to be a valid method to assess sedation and agitation in 
the critically ill population20 and differentiates among behavior states (restless, calm, agitated).23  
The RASS is a 10 point scale, ranging from -5 (unarousable) to 0 (calm and alert) to +4 
(combative), based on observation of specific patient behaviors. It has been validated against a 
visual analogue scale of sedation and agitation and tested for inter-rater reliability in 5 adult 
ICUs.24  It has also been validated against other published sedation scales and tested for 
reliability using bedside nurses compared to trained instructors.24 Additional reliability and 
validity was demonstrated in a prospective cohort study of 38 medical ICU patients for reliability 
testing (46% receiving mechanical ventilation) and an independent cohort of 275 patients 
receiving mechanical ventilation for validity testing.25 The RASS demonstrates excellent inter-
rater reliability and criterion, construct, and face validity and is the first sedation scale to be 
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validated for its ability to detect changes in sedation status over consecutive days of ICU care, 
against constructs of level of consciousness and delirium, and correlates with the administered 
dose of sedative and analgesic medications. The RASS is a broadly used sedation-agitation 
scale and is routinely used in the target ICU.  In the recently published clinical practice 
guidelines for managing pain, agitation, and delirium from the Society of Critical Care 
Medicine26, the RASS received the highest score among all sedation/ agitation instruments for 
psychometric properties and strength of evidence for utility.  
Respiratory rate.  Respiratory patterns, specifically respiratory rate may affect ETT 
movement, as the ETT may move with each ventilated and/or spontaneous breath.  To 
determine the amount of ETT movement that is related to factors other than respiratory patterns 
measurement of respiratory rate is critical.  Therefore, breath to breath respiratory rate was 
measured continuously in real time using the Non-Invasive Cardiac Output monitor (NICO2). 
The NICO2 monitor, a device designed to measure non-invasive cardiac output (NovaMetrix 
Medical Systems, Inc., Wallingford, CT) produces a linear and calibrated output as a function of 
flow through a fixed-orifice differential pressure pneumotachometer which is attached between 
the end of the ETT and the ventilator tubing. Exhaled gas flowing through the sensor produces a 
slight pressure decrease across the two tubes connected to the sensor. This pressure decrease 
is transmitted through the tubing to a differential pressure transducer inside the monitor and is 
correlated with flow according to a factory-determined calibration. Continuous analog voltage 
signals corresponding to volume exhaled by the patient ventilator will be sampled at a rate of 
250 samples per second or every 4 milliseconds and stored for later analysis.  
Nursing care and patient activities.  A variety of nursing care activities may also affect 
ETT movement and result in changes in ETT cuff pressure, potentially increasing patient risk.27  
Although ETT cuff pressure was not monitored in this study, description of ETT movement is the 
first step to determine its associated risks.  During a pilot study, a list of common nursing 
activities that may affect ETT movement, including patient responses, was devised, revised and 
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validated. (Table 1)  These activities were recorded categorically through an electronic 
observation recording system that allowed simultaneous events to be recorded in real time.  
Subject Demographics. Information was obtained to describe the sample and included 
subject age, gender, race/ethnicity, duration of endotracheal intubation (in hours), ICU length of 
stay (in days), ventilatory settings and severity of illness. Individual patient differences related to 
severity of illness may also affect patient response to ETT movement. Patients who have 
greater severity of illness may require higher doses of opioids and sedatives which deepen 
sedation levels and may affect ETT movement. Therefore severity of illness was documented 
on study enrollment using the APACHE III.28 The APACHE III is based on the concept that the 
pretreatment risk of death of an acutely ill patient is determined by type of disease, physiologic 
reserve, and severity of disease. The APACHE III scoring system has been validated and widely 
used to stratify patients into well-defined groups and to ensure that research treatment and 
control groups had equivalent severity of illness.29 
Procedures 
 An in-service about the study was provided to the unit nurse managers, nursing staff 
members and respiratory therapists prior to study implementation and to inform the staff of the 
study purpose and procedures. Daily rounds were made in the MRICU by one of the 
investigators (AH) to evaluate patients as potential subjects for the study, to conduct all 
informed consent processes and to enroll all subjects. Data collection was completed by one 
investigator (AH) and occurred during any period of the hospital stay as long as the inclusion 
criteria were met  
 A four hour direct observation period was used for data collection to provide a time 
frame that would ensure the capture of routine nursing care (i.e. oral care, turning of the patient, 
regular assessments), as well as any incidental movement. The timing of this 4-hour direct 
observation of the subject was not specified as to time of day to provide more flexibility in 
accommodating patient care needs and family preferences for individual subjects, since 
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examination of circadian effects was not a study focus. Data obtained did not affect the subject’s 
care and was not used in the clinical management of discomfort or agitation. The bedside nurse 
managing the care of the patient continued to evaluate the patient’s level of discomfort and 
agitation in the routine manner and was not involved in any aspect of data collection. Once the 
subject was enrolled in the study, descriptive data concerning subject demographics and ICU 
admission information was collected from the medical record along with Information for the 
APACHE III, which was based on the 24 hours prior to study enrollment.   
During the observation period the investigator sat unobtrusively by the bed and 
documented data regarding the origin of ETT movement, either initiated by staff or the patient, 
using a “toggle box” which consisted of toggle switches associated with the 8 categories of ETT 
movement (Table 1). These data were downloaded to a laptop computer and allowed for time-
stamped observation of simultaneous events that affected ETT movement.  
 Continuous measurement of ETT movement, respiratory parameter (RR), and 
actigraphy occurred during the entire four hour period. Data for intermittent measures, 
discomfort (BPS) and agitation (RASS), were collected prior to any contact with the subject, at 
baseline and again every half hour during the data collection period. In order to score the RASS, 
the subject must be stimulated to respond if not obviously awake and alert. Therefore, collection 
of the RASS data occurred after the measure of discomfort (BPS) so that the stimulation 
required for scoring the RASS did not affect the BPS.  
 Data from each continuous measurement (ETT movement, RR, actigraphy) was time 
stamped upon arrival to a laptop computer and imported into a database for further analysis. 
The time stamping of data allowed time alignment and correlation of data with other 
observational measurements. 
Data Analysis  
Data were collected 60 times per second for ETT movement, every second for 
actigraphy and with each breath for the NICO. All of these data were then averaged over a one 
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second interval to provide a common epoch across measures. The mean value for ETT 
movement, actigraphy, RR over a one minute interval was then used for analysis.  This process 
resulted in a single observation for every minute for a period of up to 4 hours for ETT 
movement, actigraphy, and RR.   
The primary aim of this study was to describe ETT movement and explore its effect on 
discomfort and the resulting agitation. To achieve this first aim, descriptive statistics were used 
to describe ETT movement, patient discomfort and agitation. Multivariate analyses were used to 
determine if ETT movement and key variables (BPS, actigraphy and RASS scores) are 
significantly related. Descriptive statistics were used to describe the amount and frequency of 
ETT movement.  
RESULTS 
Thirty-three subjects were enrolled in the study. Twelve were excluded from analysis as 
a result of deterioration in clinical status (n=3), family withdrawal of subject (n=1), equipment 
(TrakStar) failure (n=8). The majority of the sample used for this analysis (n=21) was male and 
African American with a mean age was 58 years of age (Table 2). The mean score on the Acute 
Physiology and Chronic Health Evaluation III (APACHE III) was 88.2 and the median stay in the 
ICU was 17 days.  Thirty eight percent of patients had physical restraints, with wrist restraints 
being the most commonly observed method (Table 2).   
ETT Movement.  Over the entire study period, there were 58.5 hours of direct patient 
observation with a mean of 2.8 hours of observation per patient.  The majority of subjects had 
less than the target of 4 hours of observation due to clinical demands that required removal of 
study equipment (i.e. patient travelled for diagnostic studies or nurse requested removal for 
therapeutic intervention).  However, this resulted in almost 50 hours of data for each of the 
major variables (Table 3). One subject had neither arm nor leg actigraphy data, and one subject 
had leg actigraphy only.  Eighteen subjects had data for all variables of interest -- ETT 
movement (TrakStar), agitation (actigraphy, RASS) and pain (BPS). It was noted that ETT 
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movement occurred continuously resulting in no minute of data collection without movement, 
even during times with no documented activities or events that would affect ETT movement. It 
was also noted that 83% of the observed movement of the ETT was patient initiated. 
ETT Movement, Discomfort and Agitation.  There were 132 BPS measurements over the 
observation period in the 21 subjects with a mean of 3.3, range 3 to 9. (Table 3) There was no 
significant association between ETT movement and the average Behavioral Pain Scale (r = -
.06; p = 0.78) or RASS (r = .30; p = 0.19) by subjects. Levels of ETT movement by BPS value 
are shown in Figure 1.  Multivariate analyses showed weak correlations between ETT 
movement and arm actigraphy (r = 0.11; p<.001) and ETT movement and leg actigraphy (r = 
0.07; p<.001) (Table 4).  Patterns across subjects for all continuous measurements (TrakStar, 
actigraphy) and average pain level (BPS) are shown in Figure 2. However, no obvious patterns 
were identified.  
Since the ETT moves continuously it was theorized that this continuous movement may 
be associated with respiratory patterns. Therefore an analysis of this association was 
conducted, identifying a weak correlation (r = 0.18; p<.001) but the strongest correlation among 
all variables (Table 4).  
Nursing care and patient activities.  Nursing care and patient activities were totaled by 
subject based on number and duration of activities in minutes. (Table 3)  Of the total hours of 
observation, on average 2.8 hours per subject, 26.4 minutes were spent in nursing or patient 
activities that affected ETT movement.  However, there was no association between total ETT 
movement and total time spent in any activity (r = 0.06; p = 0.81) by subject, nor were there any 
significant associations among ETT movement and any category of nursing or patient activity 
(shift vent tubing r = -0.07, p = 0.77; patient turned by staff r = -0.07, p = .78; HOB 
raised/lowered r = 0.06, p = 0.81; ETT suction r = 0.11, p = 0.79; turns head r = 0.16, p = 
0.57;shifts body r = -0.29, p = 0.37; other patient movement r = 0.10, p = 0.69). 
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DISCUSSION 
While much has been published regarding ETT migration, in terms of depth, there is very 
little known about other types of ETT movement and the effect of that movement on patient 
discomfort and agitation.  The ETT is a primary source of discomfort for intubated patients,7, 10, 11 
and further studies have shown that a topical anesthetic applied to the ETT cuff can reduce 
discomfort15 and the need for sedative and analgesic use by up to 40%.16  We found in this 
sample of critically ill subjects in the MRICU that ETT movement occurs continuously and is 
associated with measures of agitation (both arm and leg actigraphy), but not associated with a 
measure of pain (BPS). Since ETT movement was noted to be continuous, associations with 
respiratory patterns were explored and shown to also be significant, again likely due to the large 
sample size.  However, although this association was the strongest identified in this study, it 
most likely does not explain all the sources of ETT movement.  
It was expected the amount of ETT movement found would be associated with activities 
(nursing or patient) that included moving the ETT, however this was not the case.  Since the 
analysis was conducted by subject (N=20; one subject did not have activity data), it was based 
on a small sample size that may have affected the ability to detect significance.  Further 
exploration including an analysis of activities per minute may prove more fruitful in determining 
the specific factors that affect ETT movement.   
This paper reports the first description of ETT movement other than ETT migration 
(changes in depth). Critically ill patient experiences of pain and discomfort, as well as risk of 
microaspiration, are a critical focus of nursing care.  Standards of care for managing ETTs do 
not necessarily focus on ETT movement, except to ensure ETT stability related to depth. 
Although we did not find an association in this study, additional movement, as we have shown, 
occurs continuously (side to side, up and down) and may add to further pain and agitation as 
well as the potential to reduce cuff pressure resulting in microaspiration.  Patients routinely 
complain about pain and discomfort associated with the ETT.10, 11  Nurses move the ETT and 
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attached ventilator tubing frequently and may have little awareness of the effect.  Data show 
that when topical anesthetic is applied to the ETT cuff, one of the most likely areas of irritation 
during ETT movement, there was a significant reduction discomfort15 and analgesic and 
sedative use.16  One study that explored specific areas of discomfort related to the ETT found 
that when asked, almost a third of patients described the discomfort as located in the chest 
approximately at the level of the ETT cuff.10 Further exploration of the effect of ETT anesthetic is 
warranted.   
To further reduce overall risks and complications of MV, exploration of  the effect of ETT 
movement on cuff pressure changes that could increase risk of ventilator-associated events due 
to microaspiration or tracheal trauma (cuff pressure >30cm H2O) are in order. A reduction in 
these complications may have a positive impact on patient outcomes including decreasing 
duration of MV, ICU and hospital length of stay.  
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TABLE 1 
NURSING CARE AND PATIENT ACTIVITES DURING ETT MOVEMENT 
1 Shift ventilator tubing for access 
2 Patient turned by staff 
3 Raise/lower HOB 
4 ETT is re-taped/moved 
5 ET suction 
6 Patient turns head 
7 Patient shifts body  
8 Patient Movement – Other (patient coughs, attempting to speak,pulls tube, etc) 
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TABLE 2 
SAMPLE CHARACTERISTICS FOR ALL SUBJECTS ENROLLED (N=21)  
    
 Mean SD Range 
AGE (YEARS) 58.4 13.3 24 – 81 
APACHE III 88.2 26.7 47 – 154  
 
 Median IQR Range 
    
ICU LENGTH OF STAY (DAYS) 17 11.75, 22.25 1 – 72 
LENGTH HOSPITAL STAY (DAYS) 22 16.25, 30.25 1 - 117 
 
 Count Percent 
GENDER   
     MALE 14 66.7 
     FEMALE 7 33.3 
RACE   
     AFRICAN AMERICAN 12 57.1 
     CAUCASIAN 9 42.9 
RESTAINTS   
     UPPER EXTREMITY 8 38.1 
     NONE 13 61.9 
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Table 3.   Summary statistics for major study variables per observation 
 
Variable  
 
N (Subjects) 
 
N  
Minutes 
(Hours) 
 
Mean 
Minutes 
 
Range 
Minutes 
 
SD 
Minutes 
ETT Movement (cm) by minute 21 3215 (53.6) 763.6 0.3 – 17,967.2 835.5 
Arm Actigraphy (count by minute) 20 2982 (49.7) 273.4 0 – 6458 723.5 
Leg Actigraphy (count by minute) 19 3223 (53.7) 150.1 0 – 5123 373.5 
Respiratory Rate by minute 18 3077 (51.3) 16.0 5.8 – 40.7 4.9 
      
 N (Subjects) N (Total 
Scores) 
Mean Range SD 
BPS (Total Score) by measurement 21 132 3.4 3 – 9 1.0 
      
 
RASS Measurements – Scores by 
category  
 
N (152 total 
scores) 
 
Percent 
   
     restless/agitated (+1, +2, +3, or +4) 16 10.5%    
     alert/mildly sedated (-2, -1 or 0) 84 55.3%    
     moderate/deeply sedated ( -5, -4, 
or -3 
52 34.2%    
      
 N (Subjects)  
Event Count 
Duration 
(HR:MIN) 
  
Total amount of observation time   51:24   
All Events 20 752 8:48   
   Shift vent tubing for access 20 127 0:24   
   Patient turned by staff 17 53 0:46   
   Raise/lower HOB 19 53 0:15   
   ETT is re-taped/moved 2 6 0:08   
   ET suction 8 18 0:05   
   Patient turns head 15 267 1:06   
   Patient shifts body 12 250 1:00   
   Patient Movements (Other*) 18 314 5:54   
*Other = patient cough, attempting to speak, pulls tube 
RUNNING TITLE: Endotracheal Tube Movement 
 
30 
 
 
  
Table 4.    Correlations (R) among ETT Movement, Arm Actigraphy, Leg Actigraphy, 
Respiratory Rate 
 
 Arm Actigraphy Leg Actigraphy Respiratory Rate 
ETT Movement 0.11** 0.07** 0.18** 
Arm Actigraphy  0.60** 0.04* 
Leg Actigraphy   0.13** 
* p < .05;  ** p < .001 
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Figure 1.   ETT Movement (TrakStar) by Level of Pain (BPS) 
 
 
  Behavioral Pain Score – Average by Subject 
TrakStar Average Per Minute by Subjected 
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Figure 2.   Major Variables by Subject  
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APPENDIX A 
 
Richmond Agitation-Sedation Scale (RASS)* 
 
Score Term              Description 
 
+4 Combative  Overtly combative or violent. Immediate danger to staff 
 
+3 Very agitated  Pulls on or removes tube(s) or catheter(s), or has aggressive  
    behavior towards staff 
 
+2 Agitated  Frequent nonpurposeful movement or patient-ventilator 
dysynchrony 
 
+1 Restless  Anxious or apprehensive but movements not aggressive or 
vigorous 
 
0 Alert and calm 
 
-1 Drowsy  Not fully alert, but has sustained (> 10 sec) awakening, with eye 
contact, to voice 
 
-2 Light sedation  Briefly (< 10 sec) awakens with eye contact to voice 
 
-3 Moderate sedation Any movement (but no eye contact) to voice  
        
-4 Deep sedation  No response to voice, but any movement to physical stimulation 
 
-5 Unarousable  No response to voice or physical stimulation 
 
 
PROCEDURE 
1.  Observe patient.  Is patient alert and calm? (Score 0) 
Does patient have behavior consistent with restlessness or agitation? (Score +1 to +4 
using criteria listed above) 
2.  If patient is not alert, in a loud speaking voice state patient’s name and direct patient to open 
eyes and look at speaker. Repeat once if necessary. Can prompt patient to continue looking 
at speaker. 
Patient has eye opening and eye contact which is sustained for > 10 sec. (Score -1) 
Patient has eye opening and eye contact, but this is not sustained for 10 sec. (Score -2) 
Patient has any movement in response to voice, excluding eye contact. (Score -3)  
3.  If patient does not respond to voice, physically stimulate patient by shaking shoulder, then 
rubbing sternum if no response to shaking shoulder. 
 Patient has any movement to physical stimulation (Score -4) 
 Patient has no response to voice or physical stimulation (Score -5) 
  
 
*Sessler, C. N., Gosnell, M. S., Grap, M. J., Brophy, G. M., O'Neal, P. V., Keane, K. A. et al. 
(2002). The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care 
unit patients. Am.J.Respir.Crit Care Med.,166, 1338-1344. 
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APPENDIX B 
 
The Behavioral Pain Scale* 
 
Item Description Score 
 
Facial expression  Relaxed 1 
  Partially tightened (e.g., brow lowering) 2   
 Fully tightened (e.g., eyelid closing) 3   
 Grimacing 4 
 
Upper limbs No movement 1 
 Partially bent 2 
 Fully bent with finger flexion 3   
 Permanently retracted 4 
 
Compliance with  Tolerating movement 1 
ventilation Coughing but tolerating ventilation most 2 
  of the time    
 Fighting ventilator 3 
 Unable to control ventilation 4   
 
 
 
 
Each of the three categories—facial expression, upper limbs, and compliance with ventilation—
is scored from 1 to 4. The values are added together for a total score between 3 and 12. 
 
 
*From Payen, J-F., Bru, O., Bosson, J-L., Lagrasta, A., Novel, E., Deschaux, I., Lavagne, P., & 
Jacquot, C. (2001). Assessing pain in critically ill sedated patients by using a behavioral pain 
scale. Critical Care Medicine, 29(12), 2258-2263. 
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